Open access
168
Views
7
CrossRef citations to date
0
Altmetric
Review
Profile of bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination and its potential in the treatment of HIV-1 infection: evidence to date
Lucas Hill1 University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego, CA, USA, [email protected]Correspondence[email protected]
, Shawn R Smith1 University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego, CA, USA, [email protected]
& Maile Young Karris2 Department of Medicine, University of California San Diego, San Diego, CA, USA
Pages 203-213
|
Published online: 29 Oct 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.